Patrick Michael  Murphy net worth and biography

Patrick Murphy Biography and Net Worth

Patrick Murphy has served as our Chief Legal Officer since November 2021 and as our Chief Business Officer since April 2023. From January 2016 to November 2021, Mr. Murphy held various roles at DexCom, Inc., most recently as Executive Vice President and Chief Legal Officer. From September 2003 to January 2016, Mr. Murphy was an attorney at Stradling Yocca Carlson & Rauth law firm, where he specialized in corporate finance, mergers and acquisitions and general corporate matters.

Mr. Murphy received a J.D. from the St. Louis University School of Law and a B.S. from the Truman State University. Mr. Murphy is a member of the State Bar of California.

What is Patrick Michael Murphy's net worth?

The estimated net worth of Patrick Michael Murphy is at least $3.61 million as of February 29th, 2024. Mr. Murphy owns 48,962 shares of iRhythm Technologies stock worth more than $3,610,458 as of November 20th. This net worth approximation does not reflect any other assets that Mr. Murphy may own. Additionally, Mr. Murphy receives a salary of $766,930.00 as EVP at iRhythm Technologies. Learn More about Patrick Michael Murphy's net worth.

How old is Patrick Michael Murphy?

Mr. Murphy is currently 45 years old. There are 5 older executives and no younger executives at iRhythm Technologies. The oldest executive at iRhythm Technologies is Mr. Marc Rosenbaum, Senior VP of Finance & Chief Accounting Officer, who is 52 years old. Learn More on Patrick Michael Murphy's age.

What is Patrick Michael Murphy's salary?

As the EVP of iRhythm Technologies, Inc., Mr. Murphy earns $766,930.00 per year. There are 2 executives that earn more than Mr. Murphy. The highest earning executive at iRhythm Technologies is Mr. Quentin S. Blackford, President, CEO & Director, who commands a salary of $1,420,000.00 per year. Learn More on Patrick Michael Murphy's salary.

How do I contact Patrick Michael Murphy?

The corporate mailing address for Mr. Murphy and other iRhythm Technologies executives is 650 TOWNSEND STREET SUITE 500, San Francisco CA, 94103. iRhythm Technologies can also be reached via phone at (415) 632-5700 and via email at [email protected]. Learn More on Patrick Michael Murphy's contact information.

Has Patrick Michael Murphy been buying or selling shares of iRhythm Technologies?

Patrick Michael Murphy has not been actively trading shares of iRhythm Technologies within the last three months. Most recently, Patrick Michael Murphy sold 7,615 shares of the business's stock in a transaction on Thursday, February 29th. The shares were sold at an average price of $121.96, for a transaction totalling $928,725.40. Following the completion of the sale, the insider now directly owns 48,962 shares of the company's stock, valued at $5,971,405.52. Learn More on Patrick Michael Murphy's trading history.

Who are iRhythm Technologies' active insiders?

iRhythm Technologies' insider roster includes C. Bairey Merz (Director), Quentin Blackford (CEO), Mark Day (EVP), Douglas Devine (CFO), Patrick Murphy (EVP), Chad Patterson (Chief Commercial Officer), Sumi Shrishrimal (EVP, Chief Risk Officer), Mervin Smith (EVP of Business Operations), Minang Turakhia (Chief Medical Officer, Chief Scientific Officer and EVP, Product Innovation), David Vort (EVP), and Daniel Wilson (EVP). Learn More on iRhythm Technologies' active insiders.

Are insiders buying or selling shares of iRhythm Technologies?

In the last year, iRhythm Technologies insiders bought shares 2 times. They purchased a total of 6,944 shares worth more than $521,860.64. In the last year, insiders at the sold shares 12 times. They sold a total of 66,532 shares worth more than $6,937,400.34. The most recent insider tranaction occured on November, 4th when Director Abhijit Y Talwalkar bought 6,664 shares worth more than $500,866.24. Insiders at iRhythm Technologies own 0.7% of the company. Learn More about insider trades at iRhythm Technologies.

Information on this page was last updated on 11/4/2024.

Patrick Michael Murphy Insider Trading History at iRhythm Technologies

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/29/2024Sell7,615$121.96$928,725.4048,962View SEC Filing Icon  
3/3/2023Sell571$117.23$66,938.3332,437View SEC Filing Icon  
See Full Table

Patrick Michael Murphy Buying and Selling Activity at iRhythm Technologies

This chart shows Patrick Michael Murphy's buying and selling at iRhythm Technologies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

iRhythm Technologies Company Overview

iRhythm Technologies logo
iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
Read More

Today's Range

Now: $73.74
Low: $72.36
High: $75.15

50 Day Range

MA: $72.82
Low: $57.07
High: $89.50

2 Week Range

Now: $73.74
Low: $55.92
High: $124.11

Volume

558,042 shs

Average Volume

613,413 shs

Market Capitalization

$2.31 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.23